- For eight consecutive years, ranked among the nation's 50 best hospitals for cardiology and heart surgery by U.S. News & World Report.
- Ranked for two consecutive years as one of the nation's 50 Top Cardiovascular Hospitals by Thomson Reuters.
- Earned the Society of Thoracic Surgeons 3 Star quality rating, the highest possible. Only 10 percent of heart surgery programs receive this rating.
Heart Valve Center
The University of Kansas Hospital's Heart Valve Center provides advanced treatment for heart valve disorders. As part of the region's premier academic medical center, our care team uses evidence based measures to deliver excellent outcomes.
Our high volume valve replacement and repair program offers expertise for complex cases. Our surgeons treat many patients who have been considered too high-risk by other cardiac care programs.
- Treatment for rare valvular disorders
- Multiple concomitant procedures, such as combined coronary bypass surgery and valve replacement
- Combined valve and arrhythmia surgery
- Leading edge imaging technology, including cardiac MRI and the high speed Flash CT scanner
- Transesophageal cardiograms performed in the operating room by board-certified anesthesiologists for every surgical patient
- Specialized cardiac pre- and post-operative care and cardiovascular intensive care
As a referral center supporting providers throughout the region, we see many high-risk and critically ill patients. Yet our mortality rates are lower than expected. We are able to deliver excellent outcomes by focusing on less invasive procedures, which require smaller incisions and fewer transfusions and result in fewer complications.
Reduced need for transfusions
To improve outcomes, we continually take steps to reduce the need for transfusions during surgery.
- Test and treat patients for anemia
- Reduce patient blood loss during surgery through medication and by recirculating blood and oxygen
- Reduce amount of blood drawn after surgery or during hospitalization.
We use significantly fewer blood products during cardiothoracic surgery than other hospitals in the Society of Thoracic Surgeons database. For aortic valve replacement, our usage was nearly half of the national benchmark.
- Minimally invasive aortic and mitral valve surgery
- Tricuspid valve replacement
- Totally endoscopic robotic mitral valve repair
- Totally endoscopic robotic atrial septal defect closure
- Mitral valve repair
- Aortic root sparing/repairing options
- Stentless aortic valve replacement
- Adult congenital surgery
- Surgery for atrial fibrillation, including minimally invasive options
- Complex repair of ascending and descending thoracic aortic aneurysms, including endovascular options
- Reoperative cardiovascular surgery
- Surgery for endocarditis
Percutaneous valve treatments
- CoreValve trial evaluation of percutaneous aortic valve implantation
- Access to FDA-approved Edwards Sapien valve, a stentless tissue valve for transaortic valve replacement
- Initiation of percutaneous program for pulmonary valve replacement